The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes

Pharmaceutical agonists of peroxisome proliferator-activated receptors (PPARs) are widely used in the management of type 2 diabetes, chiefly as lipid-lowering agents and oral hypoglycaemic agents. Although most of the focus has been placed on their cardiovascular effects, both positive and negative,...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, M. C., Jandeleit-Dahm, K. A., Tikellis, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289856/
https://www.ncbi.nlm.nih.gov/pubmed/22448165
http://dx.doi.org/10.1155/2012/456529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289856/
https://www.ncbi.nlm.nih.gov/pubmed/22448165
http://dx.doi.org/10.1155/2012/456529

Ejemplares similares